Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03VYZ
|
||||
| Former ID |
DIB000248
|
||||
| Drug Name |
MRX-4
|
||||
| Synonyms |
Non-steroidal multifunctional anti-inflammatory drug (MFAID) (nasal spray, allergic rhinitis), Morria
|
||||
| Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Phase 2 | [548571] | ||
| Company |
Morria Biopharmaceuticals plc
|
||||
| Target and Pathway | |||||
| Target(s) | Phospholipase A2 | Target Info | Inhibitor | [551190] | |
| BioCyc Pathway | Phospholipases | ||||
| Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | ||||
| WikiPathways | Glycerophospholipid biosynthesis | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.